18F-FDG-PET/CT in relapsed multiple myeloma: Are prognostic thresholds different from first-line therapy? - Romans Zukovs; Christina Antke; Eduards Mamlins; Lino Morris Sawicki; Annemarie Mohring; David Lopez y Niedenhoff; Amelie Boquoi; Mustafa Kondakci; Gerald Antoch; Hans-Wilhelm Müller; Roland Fenk; Rainer Haas (BMC Medical Imaging, 2022)

Wearable based monitoring and self-supervised contrastive learning detect clinical complications during treatment of Hematologic malignancies. - Malte Jacobsen; Rahil Gholamipoor; Till Anselm Dembek; Pauline Rottmann; Marlo Verket; Julia Brandts; Paul Jäger 003; Ben-Niklas Baermann; Mustafa Kondakci; Lutz Heinemann; Anna L. Gerke; Nikolaus Marx; et al. (npj Digit. Medicine, 2023)